<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>53 patients with the <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) were classified according to the proposals of the FAB cooperative group 1982 </plain></SENT>
<SENT sid="1" pm="."><plain>29 patients had refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA), 10 refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blasts ( <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> ), 5 RAEB in transformation, 7 RA with ringed sideroblasts and 2 <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_501'>myelomonocytic leukaemia</z:mpath> ( <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> ) </plain></SENT>
<SENT sid="2" pm="."><plain>Counting blast cells type I and II involved no difficulties </plain></SENT>
<SENT sid="3" pm="."><plain>4 of 15 patients who developed <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) according to the FAB classification of 1976 did not fulfill the new 1982 criteria for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>A redefinition of the blast cell type II to include a more granulated blast cells, without the characteristics of promyelocytes, would solve this problem </plain></SENT>
<SENT sid="5" pm="."><plain>We conclude that a redefinition of the blast cell type II might turn out to be useful </plain></SENT>
</text></document>